Comparing Abbott m2000 RealTime HIV test and Roche COBAS Ampliprep/COBAS Taqman HIV test, v2.0 in treated HIV-1 B and non-B subjects with low viraemia

被引:6
作者
Margariti, Apostolia [1 ]
Chatzidimitriou, Dimitrios [1 ]
Metallidis, Simeon [2 ]
Pilalas, Dimitrios [2 ]
Kourelis, Andreas [1 ]
Papadimitriou, Evangelia [1 ]
Haidich, Anna-Bettina [3 ]
Malisiovas, Nicolaos [1 ]
Skoura, Lemonia [1 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, Natl AIDS Reference Ctr Northern Greece, GR-54006 Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Sch Med, Div Infect Dis, Dept Internal Med 1, GR-54006 Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Sch Med, Dept Hyg & Epidemiol, GR-54006 Thessaloniki, Greece
关键词
viral load; real time PCR; HIV subtype; agreement study; LOW-LEVEL VIREMIA; VIRAL LOAD; 50; COPIES/ML; ASSAYS; RNA; AGREEMENT;
D O I
10.1002/jmv.24369
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Viral load testing is a valuable tool in HIV clinical care and research. Discrepancies among diverse viral load assays, especially with regard to non-B HIV-1 subtypes have been reported. Our study aimed to explore the impact of HIV subtype (B versus non-B) on the agreement between CAP/CTM, v2.0 and m2000 RealTime in treated HIV patients, focusing on low viral loads (<200copies/ml). Our findings indicate that there is a significant difference in the performance of the compared assays in the low-viremic range and non-B subtypes, suggesting that a single assay should be used for follow-up. J. Med. Virol. 88:724-727, 2016. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:724 / 727
页数:4
相关论文
共 22 条
  • [1] Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
  • [2] Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study
    Boillat-Blanco, Noemie
    Darling, Katharine E. A.
    Schoni-Affolter, Franziska
    Vuichard, Danielle
    Rougemont, Mathieu
    Fulchini, Rosamaria
    Bernasconi, Enos
    Aouri, Manel
    Clerc, Olivier
    Furrer, Hansjakob
    Gunthard, Huldrych F.
    Cavassini, Matthias
    [J]. ANTIVIRAL THERAPY, 2015, 20 (02) : 165 - 175
  • [3] HIV-1 Load Comparison Using Four Commercial Real-Time Assays
    Bourlet, Thomas
    Signori-Schmuck, Anne
    Roche, Laurent
    Icard, Vinca
    Saoudin, Henia
    Trabaud, Mary-Anne
    Tardy, Jean-Claude
    Morand, Patrice
    Pozzetto, Bruno
    Ecochard, Rene
    Andre, Patrice
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (01) : 292 - 297
  • [4] Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay
    Charpentier, Charlotte
    Choquet, Marion
    Joly, Veronique
    Yeni, Patrick
    Visseaux, Benoit
    Caseris, Marion
    Brun-Vezinet, Francoise
    Yazdanpanah, Yazdan
    Peytavin, Gilles
    Descamps, Diane
    Landman, Roland
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (10) : 2819 - 2825
  • [5] Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome
    Charpentier, Charlotte
    Landman, Roland
    Laouenan, Cedric
    Joly, Veronique
    Hamet, Gwenn
    Damond, Florence
    Brun-Vezinet, Francoise
    Mentre, France
    Descamps, Diane
    Yeni, Patrick
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (09) : 2231 - 2235
  • [6] Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for Determination of HIV-1 Viral Loads in a Cohort of Canadian Patients with Diverse HIV Subtype Infections
    Church, Deirdre
    Gregson, Daniel
    Lloyd, Tracie
    Klein, Marina
    Beckthold, Brenda
    Laupland, Kevin
    Gill, M. John
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (01) : 118 - 124
  • [7] Comparative frequencies of HIV low-level viremia between real-time viral load assays at clinically relevant thresholds
    Do, Tri
    Duncan, John
    Butcher, Ann
    Liegler, Teri
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2011, 52 : S83 - S89
  • [8] Plasma HIV-1 RNA Detection Below 50 Copies/mL and Risk of Virologic Rebound in Patients Receiving Highly Active Antiretroviral Therapy
    Doyle, Tomas
    Smith, Colette
    Vitiello, Paola
    Cambiano, Valentina
    Johnson, Margaret
    Owen, Andrew
    Phillips, Andrew N.
    Geretti, Anna Maria
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (05) : 724 - 732
  • [9] Antiretroviral Treatment of Adult HIV Infection 2014 Recommendations of the International Antiviral Society-USA Panel
    Guenthard, Huldrych F.
    Aberg, Judith A.
    Eron, Joseph J.
    Hoy, Jennifer F.
    Telenti, Amalio
    Benson, Constance A.
    Burger, David M.
    Cahn, Pedro
    Gallant, Joel E.
    Glesby, Marshall J.
    Reiss, Peter
    Saag, Michael S.
    Thomas, David L.
    Jacobsen, Donna M.
    Volberding, Paul A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (04): : 410 - 425
  • [10] Global trends in molecular epidemiology of HIV-1 during 2000-2007
    Hemelaar, Joris
    Gouws, Eleanor
    Ghys, Peter D.
    Osmanov, Saladin
    [J]. AIDS, 2011, 25 (05) : 679 - 689